| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
(Received for publication, April 25, 1995; and in revised form, August 11, 1995)
Rat PC12 cells respond to extracellular peptide growth factors in at least two distinct ways. When treated with nerve growth factor (NGF) PC12 cells exit the cell cycle and differentiate to a neuronal phenotype, whereas when treated with epidermal growth factor, they proliferate. We examined the potential role of Src homology 2 (SH2)-containing protein tyrosine phosphatases (PTPs) in the differentiation process. PC12 cells express substantial amounts of both SH-PTP1 and 2. SH-PTP1, but not SH-PTP2, becomes tyrosine phosphorylated following NGF, but not epidermal growth factor treatment. The enzymatic activity of SH-PTP1 toward an exogenous substrate following NGF treatment is increased 2-fold. We found that SH-PTP1 binds to the NGF receptor TrkA in vitro and that anti-TrkA immunoprecipitates have PTP activity. These results show that SH-PTP1 is differentially phosphorylated and activated by NGF in PC12 cells and suggest that this activation may play a role in NGF-induced differentiation.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  J.-M. Li, M. Mogi, K. Tsukuda, H. Tomochika, J. Iwanami, L.-J. Min, C. Nahmias, M. Iwai, and M. Horiuchi Angiotensin II-Induced Neural Differentiation via Angiotensin II Type 2 (AT2) Receptor-MMS2 Cascade Involving Interaction between AT2 Receptor-Interacting Protein and Src Homology 2 Domain-Containing Protein-Tyrosine Phosphatase 1 Mol. Endocrinol., February 1, 2007; 21(2): 499 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wu, M. Iwai, Z. Li, T. Shiuchi, L.-J. Min, T.-X. Cui, J.-M. Li, M. Okumura, C. Nahmias, and M. Horiuchi Regulation of Inhibitory Protein-{kappa}B and Monocyte Chemoattractant Protein-1 by Angiotensin II Type 2 Receptor-Activated Src Homology Protein Tyrosine Phosphatase-1 in Fetal Vascular Smooth Muscle Cells Mol. Endocrinol., March 1, 2004; 18(3): 666 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-J. Min, T.-X. Cui, Y. Yahata, K. Yamasaki, T. Shiuchi, H.-W. Liu, R. Chen, J.-M. Li, M. Okumura, T. Jinno, et al. Regulation of Collagen Synthesis in Mouse Skin Fibroblasts by Distinct Angiotensin II Receptor Subtypes Endocrinology, January 1, 2004; 145(1): 253 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. N. Marsh, C. I. Dubreuil, C. Quevedo, A. Lee, M. Majdan, G. S. Walsh, S. Hausdorff, F. A. Said, O. Zoueva, M. Kozlowski, et al. SHP-1 negatively regulates neuronal survival by functioning as a TrkA phosphatase J. Cell Biol., December 8, 2003; 163(5): 999 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-X. Cui, H. Nakagami, C. Nahmias, T. Shiuchi, Y. Takeda-Matsubara, J.-M. Li, L. Wu, M. Iwai, and M. Horiuchi Angiotensin II Subtype 2 Receptor Activation Inhibits Insulin-Induced Phosphoinositide 3-Kinase and Akt and Induces Apoptosis in PC12W Cells Mol. Endocrinol., September 1, 2002; 16(9): 2113 - 2123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-X. Cui, H. Nakagami, M. Iwai, Y. Takeda, T. Shiuchi, L. Daviet, C. Nahmias, and M. Horiuchi Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell Cardiovasc Res, March 1, 2001; 49(4): 863 - 871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. FOEHR, A. TATAVOS, E. TANABE, S. RAFFIONI, S. GOETZ, E. DIMARCO, M. DE LUCA, and R. A. BRADSHAW Discoidin domain receptor 1 (DDR1) signaling in PC12 cells: activation of juxtamembrane domains in PDGFR/DDR/TrkA chimeric receptors FASEB J, May 1, 2000; 14(7): 973 - 981. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Waltenberger, A. Uecker, J. Kroll, H. Frank, U. Mayr, J. D. Bjorge, D. Fujita, A. Gazit, V. Hombach, A. Levitzki, et al. A Dual Inhibitor of Platelet-Derived Growth Factor {beta}-Receptor and Src Kinase Activity Potently Interferes With Motogenic and Mitogenic Responses to PDGF in Vascular Smooth Muscle Cells : A Novel Candidate for Prevention of Vascular Remodeling Circ. Res., July 9, 1999; 85(1): 12 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Y. A. Lehtonen, L. Daviet, C. Nahmias, M. Horiuchi, and V. J. Dzau Analysis of Functional Domains of Angiotensin II Type 2 Receptor Involved in Apoptosis Mol. Endocrinol., July 1, 1999; 13(7): 1051 - 1060. [Abstract] [Full Text]
|
|
|
|
 |
|
 Q. Dong, K. A. Siminovitch, L. Fialkow, T. Fukushima, and G. P. Downey Negative Regulation of Myeloid Cell Proliferation and Function by the SH2 Domain-Containing Tyrosine Phosphatase-1 J. Immunol., March 15, 1999; 162(6): 3220 - 3230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Delibrias, J. E. Floettmann, M. Rowe, and D. T. Fearon Downregulated Expression of SHP-1 in Burkitt Lymphomas and Germinal Center B Lymphocytes J. Exp. Med., November 3, 1997; 186(9): 1575 - 1583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Tsoulfas, R. M. Stephens, D. R. Kaplan, and L. F. Parada TrkC Isoforms with Inserts in the Kinase Domain Show Impaired Signaling Responses J. Biol. Chem., March 8, 1996; 271(10): 5691 - 5697. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |
